NAC Infusion Dosage
For acetaminophen overdose in adults, administer intravenous N-acetylcysteine at a total dose of 300 mg/kg over 21 hours using the FDA-approved 3-bag regimen: 150 mg/kg loading dose over 1 hour, followed by 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours 1.
Acetaminophen Overdose Dosing
Standard 3-Bag Regimen (FDA-Approved)
The FDA-labeled regimen remains the standard approach in the United States 1:
- Loading dose: 150 mg/kg IV over 1 hour
- Second dose: 50 mg/kg IV over 4 hours
- Third dose: 100 mg/kg IV over 16 hours
- Total duration: 21 hours
- Total dose: 300 mg/kg
Critical preparation requirement: NAC must be diluted before administration as it is hyperosmolar (2600 mOsmol/L). Use sterile water for injection, 0.45% sodium chloride, or 5% dextrose in water 1.
When to Initiate Treatment
Administer NAC to patients with acetaminophen levels above the "possible" toxicity line on the Rumack-Matthew nomogram, ideally within 8-10 hours post-ingestion 2. The evidence strongly supports this timing:
- Treatment within 8 hours: 0% severe hepatotoxicity 2
- Treatment 8-10 hours: minimal hepatotoxicity (1 case in 62 patients) 2
- Treatment 10-24 hours: 53% severe hepatotoxicity with 5% mortality 2
Do not administer NAC to patients with levels below the "possible" toxicity line when the time of ingestion is known and the sample was obtained >4 hours post-ingestion 2, 1.
When to Continue or Extend Treatment
After completing the loading dose, determine continuation based on 1:
Continue full 21-hour course if:
- Acetaminophen level above the possible toxicity line
- Acetaminophen level could not be obtained
- Any uncertainty about hepatotoxicity risk
Discontinue NAC if:
- Acetaminophen level below possible toxicity line AND
- Time of ingestion known AND
- Sample obtained >4 hours post-ingestion
Extend beyond 21 hours if 1:
- Acetaminophen levels still detectable after final dose
- ALT/AST still rising
- INR remains elevated
- Suspected massive overdose
- Concomitant ingestion of other substances
- Pre-existing liver disease
For extended therapy guidance, contact poison control at 1-800-222-1222 1.
Alternative Regimens
While the FDA regimen is standard in the US, alternative protocols exist with similar efficacy but potentially fewer adverse reactions 3, 4:
Two-Bag Regimen (Australian/New Zealand)
- 200 mg/kg over 4 hours, then 100 mg/kg over 16 hours
- Significantly reduced adverse reactions compared to 3-bag regimen 4
- Total duration: 20 hours
SNAP Protocol (Scottish and Newcastle)
- 300 mg/kg over 12 hours
- Extended only when stopping criteria not met 3
Important caveat: These alternative regimens are not FDA-approved in the US. A 2024 survey found approximately two-thirds of US hospitals still use the FDA regimen, with changes to alternatives driven by simplicity, error reduction, and decreased adverse events 5.
Special Populations and Situations
Massive Overdose (>300 mcg/mL at 4 hours)
Controversial area: Some guidelines recommend increased NAC dosing for massive overdoses (levels >2× the nomogram line) 4, but recent evidence suggests standard-dose NAC initiated within 8 hours prevented hepatotoxicity in 91% of massive overdose cases 6. A 2022 study found no statistical difference in hepatotoxicity rates between standard and high-dose NAC regimens 7.
Practical approach: Use standard dosing if treatment initiated within 8 hours. Consider increased dosing and early hepatology consultation for:
- Treatment delay >8 hours with massive overdose
- Rising transaminases despite NAC
- Coingestions or pre-existing liver disease
Repeated Supratherapeutic Ingestion (RSI)
The Rumack-Matthew nomogram does not apply to RSI 1. For RSI (>4 g/24 hours over >8 hours):
Obtain:
- Acetaminophen level
- AST, ALT, bilirubin, INR
- Creatinine, BUN, glucose, electrolytes
Contact poison control (1-800-222-1222) for specific dosing guidance 1. One study showed 15% of RSI patients with hepatotoxicity (AST 50-1000 IU/L) progressed to severe hepatotoxicity 2.
Monitoring and Safety
Hypersensitivity Reactions
Acute hypersensitivity reactions occur most commonly during the loading dose 1. Manifestations include:
- Flushing and erythema (most common, often self-limited)
- Rash, hypotension, wheezing, bronchospasm
Management approach:
- Mild flushing/erythema: Continue infusion with observation
- More severe reactions: Immediately stop infusion, treat with antihistamines, consider restarting at slower rate
- Use extreme caution in asthmatics - one death from bronchospasm reported 1
Required Monitoring Throughout Treatment
- Hepatic function (AST, ALT, bilirubin)
- Renal function (creatinine, BUN)
- Coagulation (INR)
- Electrolytes and fluid balance 1
Common Pitfalls
Dosing errors are frequent - the 3-bag regimen produces medication errors in approximately 13.5 per 100 administrations 8. Double-check calculations and infusion rates.
Weight capping confusion - more than one-third of institutions don't use a maximum dosing weight 5. Follow your institutional protocol or use actual body weight.
Premature discontinuation - when in doubt about hepatotoxicity risk, complete the full treatment course 1.
Delayed presentation - hepatotoxicity risk increases dramatically after 10 hours. Even late treatment (10-24 hours) is beneficial compared to no treatment 2.
Mucolytic Therapy
NAC is not routinely used intravenously for mucolytic therapy. For respiratory indications, NAC is administered via nebulization or direct instillation, not IV infusion. The question specifically asks about IV dosing, which is indicated for acetaminophen overdose, not mucolytic therapy.